125 related articles for article (PubMed ID: 38299362)
1. Multifunctional siRNA/ferrocene/cyclodextrin nanoparticles for enhanced chemodynamic cancer therapy.
Raj G; Vasudev DS; Christopher S; Babulal A; Harsha P; Ram S; Tiwari M; Sauer M; Varghese R
Nanoscale; 2024 Feb; 16(7):3755-3763. PubMed ID: 38299362
[TBL] [Abstract][Full Text] [Related]
2. Pillar[6]arene-Based Supramolecular Nanocatalysts for Synergistically Enhanced Chemodynamic Therapy by the Intracellular Cascade Reaction.
Liu X; Liu J; Meng C; Zhu P; Liu X; Qian J; Ling S; Zhang Y; Ling Y
ACS Appl Mater Interfaces; 2021 Nov; 13(45):53574-53585. PubMed ID: 34729975
[TBL] [Abstract][Full Text] [Related]
3. A multivalent polyphenol-metal-nanoplatform for cascade amplified chemo-chemodynamic therapy.
Li S; Zhao Y; Ma W; Wang D; Liu H; Wang W; Peng D; Yu CY; Wei H
Acta Biomater; 2024 Jan; 173():389-402. PubMed ID: 37967695
[TBL] [Abstract][Full Text] [Related]
4. Iron-siRNA Nanohybrids for Enhanced Chemodynamic Therapy via Ferritin Heavy Chain Downregulation.
Wang J; Ding H; Zhu Y; Liu Y; Yu M; Cai H; Ao R; Huang H; Gong P; Liao Y; Chen Z; Lin L; Chen X; Yang H
Angew Chem Int Ed Engl; 2023 May; 62(22):e202302255. PubMed ID: 36959091
[TBL] [Abstract][Full Text] [Related]
5. Redox-Active Ferrocene Quencher-Based Supramolecular Nanomedicine for NIR-II Fluorescence-Monitored Chemodynamic Therapy.
Yu M; Ye Z; Liu S; Zhu Y; Niu X; Wang J; Ao R; Huang H; Cai H; Liu Y; Chen X; Lin L
Angew Chem Int Ed Engl; 2024 Mar; 63(10):e202318155. PubMed ID: 38109458
[TBL] [Abstract][Full Text] [Related]
6. Cyclodextrin-based supramolecular nanoparticles break the redox balance in chemodynamic therapy-enhanced chemotherapy.
Xing C; Chen H; Guan Y; Zhang S; Tong T; Ding N; Luo T; Kang Y; Pang J
J Colloid Interface Sci; 2022 Dec; 628(Pt B):864-876. PubMed ID: 36029600
[TBL] [Abstract][Full Text] [Related]
7. Supramolecular Polymerization-Induced Nanoassemblies for Self-Augmented Cascade Chemotherapy and Chemodynamic Therapy of Tumor.
Yang K; Yu G; Yang Z; Yue L; Zhang X; Sun C; Wei J; Rao L; Chen X; Wang R
Angew Chem Int Ed Engl; 2021 Aug; 60(32):17570-17578. PubMed ID: 34041833
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment responsive polypeptide-based supramolecular nanoprodrugs for combination therapy.
Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Dong CM; Yao Y
Acta Biomater; 2022 Jul; 146():396-405. PubMed ID: 35470074
[TBL] [Abstract][Full Text] [Related]
9. pH-responsive Mannose-modified ferrocene Metal-Organic frameworks with rare earth for Tumor-targeted synchronous Chemo/Chemodynamic therapy.
Dong J; Ma K; Ding J; Pei Y; Pei Z
Bioorg Med Chem; 2022 Sep; 69():116885. PubMed ID: 35752144
[TBL] [Abstract][Full Text] [Related]
10. ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatment.
Chen H; Xing C; Lei H; Yan B; Zhang H; Tong T; Guan Y; Kang Y; Pang J
J Control Release; 2024 Apr; 368():637-649. PubMed ID: 38484895
[TBL] [Abstract][Full Text] [Related]
11. Ferrocene-based multifunctional nanoparticles for combined chemo/chemodynamic/photothermal therapy.
Yang J; Yang L; Li Q; Zhang L
J Colloid Interface Sci; 2022 Nov; 626():719-728. PubMed ID: 35820207
[TBL] [Abstract][Full Text] [Related]
12. Conjugated Polymer-Ferrocence Nanoparticle as an NIR-II Light Powered Nanoamplifier to Enhance Chemodynamic Therapy.
He Y; Jin X; Guo S; Zhao H; Liu Y; Ju H
ACS Appl Mater Interfaces; 2021 Jul; 13(27):31452-31461. PubMed ID: 34197086
[TBL] [Abstract][Full Text] [Related]
13. Amplification of oxidative stress with a hyperthermia-enhanced chemodynamic process and MTH1 inhibition for sequential tumor nanocatalytic therapy.
Song Q; Zhang Y; Deng X; Zhao H; Zhang Y; Li J; Chen W; Hu H; Zhang Y
J Mater Chem B; 2023 May; 11(17):3836-3850. PubMed ID: 36976579
[TBL] [Abstract][Full Text] [Related]
14. pH-Activatable copper-axitinib coordinated multifunctional nanoparticles for synergistic chemo-chemodynamic therapy against aggressive cancers.
Ji M; Liu H; Wang H; Liang X; Wei M; Shi D; Gou J; Yin T; He H; Tang X; Zhang Y
Biomater Sci; 2023 Sep; 11(18):6267-6279. PubMed ID: 37545202
[TBL] [Abstract][Full Text] [Related]
15. A chemodynamic nanoenzyme with highly efficient Fenton reaction for cancer therapy.
Qiao L; Li X; Wei C; Li Z; Han S; Cheng D
Biomed Mater; 2023 Aug; 18(5):. PubMed ID: 37567189
[TBL] [Abstract][Full Text] [Related]
16. Ferrocene-containing polymersome nanoreactors for synergistically amplified tumor-specific chemodynamic therapy.
Wang Y; Zhang S; Wang J; Zhou Q; Mukerabigwi JF; Ke W; Lu N; Ge Z
J Control Release; 2021 May; 333():500-510. PubMed ID: 33848558
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular Self-Assemblies with Self-Supplying H
Bai Y; Shang Q; Wu J; Zhang H; Liu C; Liu K
ACS Appl Mater Interfaces; 2022 Aug; 14(33):37424-37435. PubMed ID: 35947436
[TBL] [Abstract][Full Text] [Related]
18. Stimulus-responsive drug/gene delivery system based on polyethylenimine cyclodextrin nanoparticles for potential cancer therapy.
Mousazadeh H; Bonabi E; Zarghami N
Carbohydr Polym; 2022 Jan; 276():118747. PubMed ID: 34823779
[TBL] [Abstract][Full Text] [Related]
19. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
20. A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor.
Fitzgerald KA; Malhotra M; Gooding M; Sallas F; Evans JC; Darcy R; O'Driscoll CM
Int J Pharm; 2016 Feb; 499(1-2):131-145. PubMed ID: 26721726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
